WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Amiodarone, Delayed repolarisation which leads to An increase in the effective refractory period (ERP), 300mg IV slow push (or 2-4mg/kg) Additional 150mg IV slow push may be considered 3-5 mins after first May require infusion of 15mg/kg over 24 hrs if rhythm is reverted acting as anti-disrhythmic agents Class II, 300mg IV slow push (or 2-4mg/kg) Additional 150mg IV slow push may be considered 3-5 mins after first May require infusion of 15mg/kg over 24 hrs if rhythm is reverted acting as anti-disrhythmic agents Class III, 300mg IV slow push (or 2-4mg/kg) Additional 150mg IV slow push may be considered 3-5 mins after first May require infusion of 15mg/kg over 24 hrs if rhythm is reverted acting as anti-disrhythmic agents Class IV, Pulseless ventricular tachycardia administer 300mg IV slow push (or 2-4mg/kg) Additional 150mg IV slow push may be considered 3-5 mins after first May require infusion of 15mg/kg over 24 hrs if rhythm is reverted, AMIODARONE indications Ventricular fibrillation, Increased action potential duration which consequently Prevents multiple compounded action potentials from occurring, the Liver excreted via Biliary route, Class III activates Potassium channel blockade, Potassium channel blockade resulting in Delayed repolarisation, AMIODARONE indications Prophylaxis for recurrent VF or VT, Ventricular fibrillation administer 300mg IV slow push (or 2-4mg/kg) Additional 150mg IV slow push may be considered 3-5 mins after first May require infusion of 15mg/kg over 24 hrs if rhythm is reverted, Biliary route in Faeces, Cardiac perfusion facilitating Restablishment of sinus rhythm and effective cardiac contractions, An increase in the effective refractory period (ERP) which consequently Prevents multiple compounded action potentials from occurring, Class II activates Beta-adrenergic blockade, Prevents multiple compounded action potentials from occurring decreasing Cardiac oxygen requirements, Class I activates Sodium channel blockade, Class IV activates Calcium channel blockade, Heart rate resulting in Restablishment of sinus rhythm and effective cardiac contractions